July 23, 2026

Can AI Make Better Drugs? Not on Wall Street’s Timeline

 Can AI Make Better Drugs? Not on Wall Street’s Timeline

The technology has arrived in the drug lab. But should investors pay up for it?

investment News
Pharmaceuticals,Healthcare/Life Sciences,Manufacturing,Artificial Intelligence/Machine Learning,Cancer,Political/General News,Computer Science,Health,Medical Conditions (Discontinued from 14th July 2026),Sciences/Humanities,Content Types,Columns,SYND,WSJ-PRO-WSJ.com,GCAPI,Eli Lilly,LLY,Novartis,NOVN.EB,CH:NOVN,Eli Lilly’s,Novartis’s,LINK:EN|drn:realtime.linkedarticle.DNCO20260712000037,LINK|i1-WP-WSJ-0003725637,LINK|i2-WP-WSJ-0003725637,artificial intelligence,machine learning,political,general news,sciences,humanities,healthcare,life sciences

Author

  • Peter Lynch

    Lynch co-authored several bestselling investment classics, including One Up on Wall Street, Beating the Street, and Learn to Earn. Known for his accessible and common-sense approach to the stock market, he coined the famous investment mantra, "Invest in what you know." This philosophy empowers everyday individual investors to find market-beating opportunities by observing consumer trends and products in their own daily lives before Wall Street notices them.Beyond his writing and investing career, Lynch is a prominent philanthropist. He works actively through the Lynch Foundation to support education, medical research, and cultural organizations. He continues to serve as a vice chairman of Fidelity Management & Research Company, mentoring new generations of financial analysts.

Peter Lynch

https://investmentdepartment.com

Lynch co-authored several bestselling investment classics, including One Up on Wall Street, Beating the Street, and Learn to Earn. Known for his accessible and common-sense approach to the stock market, he coined the famous investment mantra, "Invest in what you know." This philosophy empowers everyday individual investors to find market-beating opportunities by observing consumer trends and products in their own daily lives before Wall Street notices them.Beyond his writing and investing career, Lynch is a prominent philanthropist. He works actively through the Lynch Foundation to support education, medical research, and cultural organizations. He continues to serve as a vice chairman of Fidelity Management & Research Company, mentoring new generations of financial analysts.

Related post

Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
0
Would love your thoughts, please comment.x
()
x